L2 Asset Management’s Pulmonx LUNG Stock Holding History

L2 Asset Management’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-19,747	Closed	-$826	–	210
2023 Q3	$826	Buy	+19,747	New	+$229K	﹤0.01%	211

Other funds holding LUNG

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

L2 Asset Management's LUNG Position: Q4 2023 in Review

L2 Asset Management sold out of Pulmonx (LUNG) in Q4 2023, closing a stake of 19,747 shares — an estimated $826 sold.

L2 Asset Management first reported a position in LUNG in Q3 2023 and held it in 1 quarter. The position peaked at $826 in Q3 2023. 123 funds tracked by Wall St. Rank hold LUNG as of Q4 2023.

L2 Asset Management reported no remaining Pulmonx position as of Q4 2023 after selling out during the quarter.
L2 Asset Management sold 19,747 Pulmonx shares in Q4 2023, an estimated $826.
L2 Asset Management first reported a position in Pulmonx in Q3 2023 and held it in 1 quarter.
L2 Asset Management's Pulmonx position peaked at $826 in Q3 2023.
123 funds tracked by Wall St. Rank held Pulmonx as of Q4 2023.

Based on L2 Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.